Huntington National Bank’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Sell
162
-10
-6% -$1.3K ﹤0.01% 1713
2025
Q4
$20.9K Sell
172
-5
-3% -$627 ﹤0.01% 1567
2025
Q3
$19.9K Buy
177
+9
+5% +$1.05K ﹤0.01% 1600
2025
Q2
$22.5K Sell
168
-37
-18% -$4.06K ﹤0.01% 1526
2025
Q1
$13.8K Buy
205
+4
+2% +$275 ﹤0.01% 1646
2024
Q4
$12.5K Buy
201
+91
+83% +$8.47K ﹤0.01% 1691
2024
Q3
$17.3K Buy
110
+10
+10% +$1.54K ﹤0.01% 1561
2024
Q2
$15.1K Sell
100
-274
-73% -$32.9K ﹤0.01% 1549
2024
Q1
$27.7K Buy
374
+77
+26% +$6.35K ﹤0.01% 1356
2023
Q4
$23.4K Hold
297
﹤0.01% 1367
2023
Q3
$16.3K Sell
297
-58
-16% -$4.17K ﹤0.01% 1424
2023
Q2
$29.8K Buy
+355
New +$27.2K ﹤0.01% 1236

Other funds holding TMDX

Huntington National Bank's TMDX Position: Q1 2026 in Review

Huntington National Bank reduced its Transmedics (TMDX) stake by 5.8% in Q1 2026, selling an estimated $1.3K and leaving 162 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Huntington National Bank first reported a position in TMDX in Q2 2023 and has held it in 12 quarters since. The position peaked at $29.8K in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Huntington National Bank held 162 shares of Transmedics worth $16.1K as of Q1 2026.
  • Huntington National Bank sold 10 Transmedics shares in Q1 2026, an estimated $1.3K.
  • Transmedics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1713 holding.
  • Huntington National Bank first reported a position in Transmedics in Q2 2023 and has held it in 12 quarters since.
  • Huntington National Bank's Transmedics position peaked at $29.8K in Q2 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.